Citigroup upgraded shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) from a neutral rating to a buy rating in a research report sent to investors on Wednesday, MarketBeat reports. Citigroup currently has $57.00 price target on the medical device company’s stock, up from their prior price target of $40.00. A number of other analysts […]
Citigroup upgraded shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) from a neutral rating to a buy rating in a research report released on Wednesday morning, Marketbeat reports. Citigroup currently has $57.00 price target on the medical device company’s stock, up from their previous price target of $40.00. Several other analysts have also recently […]
Victory Capital Management Inc. lowered its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 86.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,484 shares of the medical device company’s stock after selling 85,256 shares during the quarter. Victory […]
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) shares gapped up before the market opened on Wednesday after Lake Street Capital raised their price target on the stock from $60.00 to $75.00. The stock had previously closed at $49.32, but opened at $52.15. Lake Street Capital currently has a buy rating on the stock. […]
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its price objective upped by Lake Street Capital from $60.00 to $75.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the medical device company’s stock. Lake Street Capital’s price objective would indicate a potential upside of […]